ArticleJournal of imaging2025
AI-Driven Automated Blood Cell Anomaly Detection: Enhancing Diagnostics and Telehealth in Hematology.
Article in Journal of imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Correction: El Othmani et al. AI-driven Automated Blood Cell Anomaly Detection: Enhancing Diagnostics and Telehealth in Hematology.Journal of imaging · 2025Article
- Artificial Intelligence in Healthcare: A Narrative Review of Recent Clinical Applications, Implementation Strategies, and Challenges.Journal of healthcare leadership · 2025Review
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hematology plays a critical role in diagnosing and managing a wide range of blood-related disorders. The manual interpretation of blood smear images, however, is time-consuming and highly dependent on expert availability. Moreover, it is particularly challenging in remote and resource-limited settings. In this study, we present an AI-driven system for automated blood cell anomaly detection, combining computer vision and machine learning models to support efficient diagnostics in hematology and telehealth contexts. Our architecture integrates segmentation (YOLOv11), classification (ResNet50), transfer learning, and zero-shot learning to identify and categorize cell types and abnormalities from blood smear images. Evaluated on real annotated samples, the system achieved high performance, with a precision of 0.98, recall of 0.99, and F1 score of 0.98. These results highlight the potential of the proposed system to enhance remote diagnostic capabilities and support clinical decision making in underserved regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.